Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (361-370 of 477) with videos related to

Pageof 48
Sort By:
Diagnostic Cytopathology|March 6, 2021
Diagnostic efficacy of ascites cell block for ovarian clear cell carcinomaHideki Iwahashi, Morikazu Miyamoto, Shinya Minabe, et al.
Breast Cancer Research and Treatment|April 22, 2020
BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapyAsuka Kawachi, Satoshi Yamashita, Eriko Okochi-Takada, et al.
Annals of Surgical Oncology|March 4, 2020
Utility of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging for Prediction of Metastasis to Sentinel and Nonsentinel Nodes in Patients with Clinically Node-Negative Breast CancerYoji Yamagishi, Tamio Yamasaki, Jiro Ishida, et al.
Oncotarget|October 23, 2018
Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profilesTakeshi Sawada, Riet Hilhorst, Savithri Rangarajan, et al.
Oncology Letters|June 27, 2024
Multiple metastases of human epidermal growth factor receptor 2‑positive, hormone receptor‑positive, pT1a pN0 breast cancer within 1 year after surgery: A case reportTakafumi Suzuki, Takahiro Einama, Miki Takushima, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 17, 2011
Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomasAkihiko Yoshida, Koji Tsuta, Hiroaki Nitta, et al.
Clinical Breast Cancer|October 15, 2013
Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifenNobuhiro Ijichi, Takashi Shigekawa, Kazuhiro Ikeda, et al.
Breast Cancer (Tokyo, Japan)|August 25, 2016
Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer SocietyShigeru Imoto, Chikako Yamauchi, Yoshifumi Komoike, et al.
Diagnostic Pathology|June 1, 2012
A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sectionsHiroaki Nitta, Brian D Kelly, Mary Padilla, et al.
Human Cell|April 5, 2014
Expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancerRyoko Kikuchi, Yoshihiro Kikuchi, Hitoshi Tsuda, et al.
Pageof 48

Showing results (361-370 of 477) with videos related to

Sort By:
Pageof 48
Diagnostic Cytopathology|March 6, 2021
Diagnostic efficacy of ascites cell block for ovarian clear cell carcinomaHideki Iwahashi, Morikazu Miyamoto, Shinya Minabe, et al.
Breast Cancer Research and Treatment|April 22, 2020
BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapyAsuka Kawachi, Satoshi Yamashita, Eriko Okochi-Takada, et al.
Annals of Surgical Oncology|March 4, 2020
Utility of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging for Prediction of Metastasis to Sentinel and Nonsentinel Nodes in Patients with Clinically Node-Negative Breast CancerYoji Yamagishi, Tamio Yamasaki, Jiro Ishida, et al.
Oncotarget|October 23, 2018
Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profilesTakeshi Sawada, Riet Hilhorst, Savithri Rangarajan, et al.
Oncology Letters|June 27, 2024
Multiple metastases of human epidermal growth factor receptor 2‑positive, hormone receptor‑positive, pT1a pN0 breast cancer within 1 year after surgery: A case reportTakafumi Suzuki, Takahiro Einama, Miki Takushima, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 17, 2011
Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomasAkihiko Yoshida, Koji Tsuta, Hiroaki Nitta, et al.
Clinical Breast Cancer|October 15, 2013
Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifenNobuhiro Ijichi, Takashi Shigekawa, Kazuhiro Ikeda, et al.
Breast Cancer (Tokyo, Japan)|August 25, 2016
Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer SocietyShigeru Imoto, Chikako Yamauchi, Yoshifumi Komoike, et al.
Diagnostic Pathology|June 1, 2012
A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sectionsHiroaki Nitta, Brian D Kelly, Mary Padilla, et al.
Human Cell|April 5, 2014
Expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancerRyoko Kikuchi, Yoshihiro Kikuchi, Hitoshi Tsuda, et al.
Pageof 48